Antibiotics Top List Of New Exclusivity Benefits In Draft Cures Legislation

Sponsors could transfer or sell some QIDP exclusivity to other products under draft bill, which also offers new exclusivity perks for orphan drugs, 505(b)(2) applications, ANDAs and biosimilars – but GPhA isn’t happy.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America